New MR analysis technique reveals brain tumor response to anti-angiogenesis therapy

A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective. In their report, investigators from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital, describe how their technique, called vessel architectural imaging, was able to identify changes in brain tumor blood vessels within days of the initiation of anti-angiogenesis therapy. Read more here.

Study mentioned: Emblem KE, et al. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nature Medicine. Published online 18 August 2013.